Factors of treatment response in major depressive disorder

Trial Profile

Factors of treatment response in major depressive disorder

Phase of Trial: Phase IV

Latest Information Update: 03 Feb 2010

At a glance

  • Drugs Duloxetine; Escitalopram; Venlafaxine
  • Indications Major depressive disorder
  • Focus Therapeutic Use
  • Most Recent Events

    • 21 Sep 2008 Status changed from recruiting to suspended as reported by Clinicaltrials.gov.
    • 11 Aug 2008 Planned number of patients changed from 120 to 140 as reported by ClinicalTrials.gov.
    • 21 Apr 2008 The expected completion date for this trial is now 1 Jun 2009.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top